Enhanced shear-induced platelet aggregation in patients who experience subacute stent thrombosis: a case-control study
about
Current status of high on-treatment platelet reactivity in patients with coronary or peripheral arterial disease: Mechanisms, evaluation and clinical implicationsAspirin and clopidogrel resistance: consideration and managementPrasugrelA history of late and very late stent thrombosis is not associated with increased activation of the contact system, a case control study.AZD6140.Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.FDA advisory panel on the safety and efficacy of drug-eluting stents: summary of findings and recommendations.Aspirin resistance: disparities and clinical implications.A clinician's perspective of emerging P2Y(12)-directed pharmacotherapies, ex vivo measurement tools, and clinical outcomes.Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonistRelation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis.Clinical value of antiplatelet therapy in patients with acute coronary syndromes and in percutaneous coronary intervention.Drug-induced thrombosis: an update.Antiplatelet Resistance-Does it Exist and How to Measure it?Antiplatelet therapy: current strategies and future trends.A point-of-care assay to measure platelet aggregation in patients taking clopidogrel.Abacavir has no prothrombotic effect on platelets in vitro.Safety and efficacy of policosanol in patients with high on-treatment platelet reactivity after drug-eluting stent implantation: two-year follow-up results.Towards personalized medicine based on platelet function testing for stent thrombosis patientsDeterminants to optimize response to clopidogrel in acute coronary syndromePoint-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with Drug-Eluting Stent Thrombosis whilst on dual antiplatelet therapy.Efficacy and safety of triple antiplatelet therapy in obese patients undergoing stent implantation.Variable therapeutic effectiveness of clopidogrel in acute coronary syndromes.Single nucleotide polymorphism of CYP3A5*3 contributes to clopidogrel resistance in coronary artery disease patients among Tamilian population.Acute myocardial infarction occurring while on chronic clopidogrel therapy ('clopidogrel failure') is associated with high incidence of clopidogrel poor responsiveness and stent thrombosis.
P2860
Q26771106-6345126C-4A13-4A17-8B0E-AD782C304090Q28200610-FA3AC67A-5E34-4A69-9802-57957B00A3EAQ28210429-EF8C09E7-87DB-4221-8C2B-A482B1B3AE90Q33854333-8AB59518-A275-4E81-8FCD-82BCAE6C9A88Q36715768-03DAFC29-A657-478A-A959-31F9CAB16473Q36941850-6C1FE1B9-CB57-41F7-B465-2A7C19B21489Q37016139-A96ED4DD-B041-4D2A-A542-CDC36A689F10Q37227512-B9851C81-8025-4990-A522-FF454A515922Q37550156-BB9540BC-20D9-43C6-B899-DDABB546BE7AQ37552005-BE293857-1010-43B6-89F9-470559F64CAAQ37693951-89453C02-45D2-4348-9907-32E846AE3416Q37841560-4400EBF4-8A08-448E-A5C9-4BD1631E4CC4Q38103820-92BD7BB5-3C1F-495E-A7DB-96DCB6856BF9Q40014803-5D14925D-A81D-49AC-8300-54938FFDDA28Q40329892-D267F62A-280F-458E-84D9-B38FFF2B8DF6Q40329955-9362B53C-67AB-491E-8CDA-3507DA030F94Q40578438-1BA57DE8-8AC6-4E4F-9CA1-EED9DEF91A4FQ40689554-768A0638-FB2A-4B84-AD76-14A48E7868CDQ41817424-5D1E6059-3DAC-4FDF-937D-3BB2DE144546Q41848961-9D745297-78B5-4C1E-85FA-BC9A54CBFC9EQ43077737-A06002C9-8487-4D27-A3F0-EAFF70A0D653Q45888145-E425CD7F-694C-478E-8B20-8835743698E5Q46888764-8A77D1F2-8EBC-4336-A9F5-DC86791B7089Q54195220-39FC4317-68DF-4909-BF14-83404F3F35BEQ55473805-041ADC3F-6DCB-49B9-AED3-0D6ABD199B1D
P2860
Enhanced shear-induced platelet aggregation in patients who experience subacute stent thrombosis: a case-control study
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Enhanced shear-induced platele ...... rombosis: a case-control study
@ast
Enhanced shear-induced platele ...... rombosis: a case-control study
@en
Enhanced shear-induced platele ...... rombosis: a case-control study
@nl
type
label
Enhanced shear-induced platele ...... rombosis: a case-control study
@ast
Enhanced shear-induced platele ...... rombosis: a case-control study
@en
Enhanced shear-induced platele ...... rombosis: a case-control study
@nl
prefLabel
Enhanced shear-induced platele ...... rombosis: a case-control study
@ast
Enhanced shear-induced platele ...... rombosis: a case-control study
@en
Enhanced shear-induced platele ...... rombosis: a case-control study
@nl
P2093
P1476
Enhanced shear-induced platele ...... rombosis: a case-control study
@en
P2093
Agnés Cachier
Dominique Himbert
Laurent J Feldman
Marie-Claude Guillin
Marie-Genevieve Huisse
Ph Gabriel Steg
Pierre Aubry
Walid El Amara
P304
P356
10.1016/J.JACC.2004.10.079
P407
P577
2005-06-07T00:00:00Z